CDC announces that more than 90% of new HIV acquisitions in the United States could be prevented by diagnosing people living with HIV and ensuring they receive prompt, ongoing care and treatment.
Indiana state health officials announce an HIV outbreak linked to injection drug use in the southeastern portion of the state. By the end of the year, Indiana will confirm 184 new cases of HIV linked to the outbreak.
Results from the Strategic Timing of AntiRetroviral Treatment (START) study indicate that individuals with HIV who start taking antiretroviral drugs before their CD4+ cell counts decrease have a considerably lower risk of developing AIDS or other serious illnesses. Subsequent data releases show that early therapy for people living with HIV also prevents the onset of cancer, cardiovascular disease, and other non-AIDS-related diseases.
Researchers report that antiretroviral therapy is highly effective at preventing sexual transmission of HIV from a person living with HIV to a heterosexual partner who does not have HIV, when partner with HIV is virally suppressed. The finding comes from the decade-long HPTN 052 clinical trial.
The WHO announces new treatment recommendations that call for all people living with HIV to begin antiretroviral therapy as soon after diagnosis as possible. WHO also recommends daily oral PrEP as an additional prevention choice for those at substantial risk for acquiring HIV. WHO estimates the new policies could help avert more than 21 million deaths and 28 million new infections by 2030.
CDC announces that annual HIV diagnoses in the U.S. fell by 19% from 2005 to 2014. There were steep declines among heterosexuals, people who inject drugs, and Black/African American people (especially Black women), but trends for gay/bisexual men varied by race/ethnicity. Diagnoses among white gay/bisexual men decreased by 18%, but they continued to rise among Latino gay/bisexual men (+24%) and Black gay/bisexual men (+22%), although the increase for the latter leveled off since 2010.